TY  - GEN
AU  - Valone,F H
AU  - Gandara,D R
AU  - Deisseroth,A B
AU  - Perez,E A
AU  - Rayner,A
AU  - Aronson,F R
AU  - Luce,J
AU  - Paradise,C
TI  - Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas
SN  - 1053-8550
PY  - 1991///0917
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Drug Evaluation
KW  - Female
KW  - Fluorouracil
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Interleukin-2
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1097/00002371-199106000-00007
ER  -